Tissue engineering market to reach $56.2b by 2032

This is due to the high demand for regenerative medication.

The global tissue engineering market is estimated to reach $56.2b by 2032, with a growth rate of 14.3% from 2024 to 2032, according to a GlobeNewswire report.

The report said it is due to the high demand for regenerative medication, the increasing number of elderly residents, and tissue scientific process discoveries.

By region, the Asia Pacific is estimated to witness the highest growth rate, due to rising healthcare expenditure, clinical trials, and rapid uptake of emerging technologies.

The orthopaedics, musculoskeletal and spine segments accounted for the largest revenue share of 59.7% in 2023, owing to the rise in the occurrence of musculoskeletal disorders.

Meanwhile, the highest growth rate of 25.9% in the forecast period is expected from the cardiology and vascular segment due to the growing prevalence of cardiovascular disorders.